HomeMCPWorkbenchSkills
HomeWorkbenchNotificationsMe
llms.txt · MCP GuidePrivacy Policy · Terms of Service · Supportv1.8.0
  1. Home
  2. /Compound

Sodium orthovanadate

HCID 61671
New noteNew reactionRequest quotes
Print preview
Basic informationOverviewNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes
Substructure searchFind similar structures

Basic information

CAS
13721-39-6
Standard SMILES
[Na+].[Na+].[Na+].[O]=[V]([O-])([O-])[O-]
InChIKey
IHIXIJGXTJIKRB-UHFFFAOYSA-N
Molecular formula
Na3-V-O4
Average molar mass
183.908 g/mol
Monoisotopic mass
183.89292582

Overview

Trisodium vanadate is an inorganic sodium salt of formula Na3VO4 containing the tetrahedral VO43. It has a role as an EC 3.1.3.48 (protein-tyrosine-phosphatase) inhibitor, an antineoplastic agent, a radiation protective agent and an apoptosis inducer. It contains a vanadate(3-).

Names & identifiers

Preferred name
Sodium orthovanadate
IUPAC
trisodium;trioxido(oxo)vanadium
English name
Sodium orthovanadate
Molecular formula
Na3VO4
Molecular weight
183.91

Names & synonyms

Sodium orthovanadate13721-39-6Trisodium vanadateSodium o-vanadateSodium pervanadateSodium vanadium oxide (Na3VO4)Sodium tetraoxovanadate(3-)Sodium vanadate (ortho)Trisodium tetraoxovanadateVanadic acid, trisodium saltTRISODIUM ORTHOVANADATEtrisodium;trioxido(oxo)vanadium
Show more names
SODIUM VANADATESodium orthavanadiumSodium Orthovanadate(Ⅴ)sodiumvanadate(v)(na3vo4)DECAVANDATEtrisodiumvanadateIs sodium vanadatePervanadate(100mM)
Vanadic acid (H3VO4), sodium saltSodium vanadate(V) (Na3VO4)MFCD00003511DTXSID20372697845MV6C8VVanadic (II) Acid, Trisodium SaltCCRIS 9063EINECS 237-287-9

Database identifiers

CAS
13721-39-6

Properties

Computed structural properties

Topological polar surface area
86.3 Ų
Hydrogen bond donors
0
Hydrogen bond acceptors
4
Rotatable bonds
0
Heavy atoms
8
Formal charge
0
Complexity
36.8

Experimental & physicochemical properties

Chemical ClassesMetals -> Metals, Inorganic Compounds
Physical DescriptionWhite odorless granules; [Alfa Aesar MSDS]

Physicochemical properties

Melting point
850 · 850-866 °C(lit.)
storage temp.
Sealed in dry,Room Temperature
solubility
2 O: · H2O: soluble
form
Solid
color
off-white
biological source
synthetic (organic)
Water Solubility
soluble
Exposure limits
0.05 mg/m3 · NIOSH: Ceiling 0.05 mg/m3
Stability
Stable. Incompatible with strong oxidizing agents.
InChI
InChI=1S/3Na.4O.V
InChIKey
HQHUIUQMQXUPHI-UHFFFAOYSA-N
SMILES
[V](=O)(O[Na])(O[Na])O[Na]

Safety & regulation

Safety information is for reference only and does not replace the supplier’s Safety Data Sheet (SDS), applicable regulations, or professional assessment.

GHS classification

GHS Classification · 5 items

This chemical does not meet GHS hazard criteria for 1.7% (1 of 59) of reports.

Warning

H302 (98.3%): Harmful if swallowed [Warning Acute toxicity, oral]

P261, P264, P270, P271, P280, P301+P317, P302+P352, P304+P340, P317, P321, P330, P362+P364, and P501 (click each P-code to see the statement)

Aggregated GHS information provided per 59 reports by companies from 5 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.

Hazard information

Regulatory Information · 2 items

Chemical: Vanadate (VO43-), trisodium, (T-4)-

Trisodium orthovanadate: Does not have an individual approval but may be used under an appropriate group standard

Hazards SummaryCauses convulsions in subcutaneous lethal-dose studies; [RTECS] A skin and strong eye irritant; Harmful by ingestion and inhalation; Reproductive effects observed in experimental animals; [Alfa Aesar MSDS] See Sodium metavanadate.
Hazard Classes and CategoriesAcute Tox. 4 (98.3%)

Safety & protection

Minimum Risk LevelAcute Inhalation: 0.0002 mg/m3 (L134) Intermediate Oral: 0.003 mg/kg/day (L134)
Protective Action Criteria (PAC) · 3 items

0.092 [mg/m3]

1.0 [mg/m3]

65 [mg/m3]

Toxicology

Chemistry & industry

Pharmacology

Metabolism/Metabolites · 1 item

Vanadium is absorbed mainly via inhalation, though small amounts can be absorbed through the skin and gastrointestional tract. It is rapidly distributed in the plasma, mainly to the kidney, liver, lungs, heart, bone, where it tends to accumulate. With the help of cytochrome P-450 enzymes, it can interconvert between its two oxidation states, vanadyl (V+4) and vanadate (V+5). Both states of vanadium can reversibly bind to transferrin protein in the blood and then be taken up into erythrocytes. Vanadium is excreted mainly in the urine. (L837)

Uses & manufacturing

Uses · 1 item

Sodium orthovanadate is often added to buffer solutions that are used in protein analysis in molecular biology. The aim is to preserve the phosphorylation of proteins of interest by inhibiting endogenous phosphatases present in cell lysate mixture. (L854)

General Manufacturing InformationSodium vanadium oxide (Na3VO4): ACTIVE
Applications · 2 items

UsesSodium orthovanadate (Na3VO4) can be used as a metal precursor in the synthesis of:Vanadium-MCM-48 (V-MCM-48) by anion-exchange method. V-MCM-48 is used as a catalyst in oxidation of styrene to benzaldehyde.Nanorods of vanadium oxide particles by glycothermal method.Yttrium vanadate (YVO4) doped with colloidal europium.

UsesSodium Orthovanadate is an inhibitor of several phosphatases and kinases. General inhibitor of tyrosine phosphatases, a large family of enzymes that catalyze the removal of phosphate groups from tyrosine residues.

Preparation methods

PreparationSodium orthovanadate is produced by dissolving vanadium(V) oxide in a solution of sodium hydroxide: V2O5 + 6 NaOH → 2 Na3VO4 + 3 H2OThe salt features tetrahedral VO3-4 anion centers linked to octahedral Na+ cation sites.

Related reactions

10 records
New reaction record
HRID 396596 reaction equation
HRID 396596As catalystuspto-grants-2003_08
HRID 741542 reaction equation
HRID 741542As catalystuspto-grants-1996_09
HRID 1112210 reaction equation
HRID 1112210As catalystuspto-grants-1978_10
HRID 1720114 reaction equation
HRID 1720114As catalystuspto-grants-1996_04
HRID 1769432 reaction equation
HRID 1769432As catalystuspto-grants-1995_01
HRID 1826099 reaction equation
HRID 1826099As catalystuspto-grants-2006_05
HRID 1857077 reaction equation
HRID 1857077As catalystuspto-grants-2000_11
HRID 1857078 reaction equation
HRID 1857078As catalystuspto-grants-2000_11
Page 1 of 2

Compound notes

Loading…

On this pageBasic informationOverviewNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes
More actions
New noteNew reactionRequest quotes
PubChem CID
61671
DTXSID
DTXSID2037269
ChEBI
CHEBI:35607
UNII
7845MV6C8V
EC Number
237-287-9
CAS DataBase Reference
13721 · 13721-39-6(CAS DataBase Reference)
FDA UNII
7845 MV6C8V · 7845MV6C8V
EPA Substance Registry System
Sodium vanadium oxide (Na3VO4) (13721-39-6)
UNSPSC Code
12352202 · 12352202
NACRES
77 · NA.77
Symbol(GHS)
7 · GHS07
Signal word
Warning
Hazard statements
302 · H302+H312+H332-H315-H319
Precautionary statements
261 · P261-P280-P301+P312-P302+P352+P312-P304+P340+P312-P305+P351+P338
PPE
95 · dust mask type N95 (US), Eyeshields, Faceshields, Gloves
Hazard Codes
Xn
Risk Statements
20 · 20/21/22
Safety Statements
22 · 22-36
RIDADR
3285 · UN3285
WGK Germany
3 · 3
RTECS
1120000 · YW1120000
TSCA
TSCA listed
HazardClass
6.1 · 6.1
PackingGroup
III
HS Code
28419030 · 28419030
Storage Class
13 · 13 - Non Combustible Solids
Hazard Classifications
4 DermalAcute · Acute Tox. 4 DermalAcute Tox. 4 InhalationAcute Tox. 4 OralEye Irrit. 2Skin Irrit. 2
Treatment · 1 item

EYES: irrigate opened eyes for several minutes under running water. INGESTION: do not induce vomiting. Rinse mouth with water (never give anything by mouth to an unconscious person). Seek immediate medical advice. SKIN: should be treated immediately by rinsing the affected parts in cold running water for at least 15 minutes, followed by thorough washing with soap and water. If necessary, the person should shower and change contaminated clothing and shoes, and then must seek medical attention. INHALATION: supply fresh air. If required provide artificial respiration.

Health EffectsBreathing high levels of vanadium affects the lungs, throat, and eyes. Ingestion of vanadium may cause kidney and liver damage, birth defects, or death. (L837)
Exposure RoutesOral (L837) ; inhalation (L837) ; dermal (L837)
Toxicity Summary · 1 item

Vanadium damages alveolar macrophages by decreasing the macrophage membrane integrity, thus impairing the cells' phagocytotic ability and viability. The pentavalent form of vanadium, vanadate, is a potent inhibitor of the Ca+-ATPase and Na+,K+-ATPase of plasma membranes, which decreases intracellular ATP concentration. Vanadium is also believed to induce the production of reactive oxygen species. This may damage DNA and also cause oxidative stress, which can damage the reproductive system. Vanadium also inhibits protein tyrosine phosphatases, producing insulin-like effects. (L837, A247, A248, A249, A250, A251)

Signs and SymptomsInhalation of vanadium causes lung irritation, coughing, wheezing, chest pain, runny nose, and a sore throat. (L837)
Carcinogen ClassificationNo indication of carcinogenicity to humans (not listed by IARC).

Safety data

PPE
dust mask type N95 (US), Eyeshields, Faceshields, Gloves
wgk
3
tsca
TSCA listed
rtecs
YW1120000
ridadr
UN3285
hs_code
28419030
risk_code
20/21/22
Signal word
Warning
Symbol(GHS)
GHS07
hazard_code
Xn
safety_code
22-36
hazard_class
6.1
Storage Class
13 - Non Combustible Solids
packing_group
III
Hazard statements
H302+H312+H332-H315-H319
Hazard Classifications
Acute Tox. 4 DermalAcute Tox. 4 InhalationAcute Tox. 4 OralEye Irrit. 2Skin Irrit. 2
Precautionary statements
P261-P280-P301+P312-P302+P352+P312-P304+P340+P312-P305+P351+P338

Upstream & downstream products

Upstream raw materials

Vanadium(V) oxideSodium hydroxide

Downstream products

Ammonium metavanadate
Additional notes · 1 item

DefinitionChEBI: Trisodium vanadate is an inorganic sodium salt of formula Na3VO4 containing the tetrahedral VO4(3-) It has a role as an EC 3.1.3.48 (protein-tyrosine-phosphatase) inhibitor, a radiation protective agent, an apoptosis inducer and an antineoplastic agent. It contains a vanadate(3-).